@Article{信息:doi 10.2196 / /移动医疗。7178，作者=“孙云恒和姜，冯和谷，娟和王，肯和华，宏伟和李，静和程，志军和廖，志军和黄，钱和胡，伟伟和丁刚”，标题=“手机智能疼痛管理系统(IPMS)的开发和测试，通过中国癌症患者的随机试验;“癌症疼痛管理新途径”，期刊=“JMIR Mhealth Uhealth”，年=“2017”，月=“7”，日=“25”，卷=“5”，数=“7”，页=“e108”，关键词=“癌症疼痛;智能疼痛管理系统;智能手机;背景:在过去的几十年中，癌症在中国变得越来越普遍。在决定癌症患者生活质量的因素中，疼痛被普遍认为是最关键的因素;它还可能导致癌症的无效治疗。在对癌症患者更好的疼痛管理需求的驱动下，我们的研究团队开发了一种基于移动的智能疼痛管理系统(IPMS)。目的:我们的目的是设计、开发和测试IPMS，以促进癌症疼痛患者的实时疼痛记录和及时干预。 The system's usability, feasibility, compliance, and satisfaction were also assessed. Methods: A sample of 46 patients with cancer pain symptoms were recruited at the Oncology Center of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch (hereinafter referred to as ``the Oncology Center''). In a pretest, participants completed a pain management knowledge questionnaire and were evaluated using the baseline cancer pain assessment and Karnofsky Performance Status (KPS) evaluation. The participants were then randomly assigned into two groups (the trial group and the control group). After a 14-day trial period, another round of cancer pain assessment, KPS evaluation and pain management knowledge assessment were repeated. In the trial group, the data were fully automatically collected by the IPMS. In the control group, the data were collected using conventional methods, such as phone interviews or door-to-door visits by physicians. The participants were also asked to complete a satisfaction questionnaire on the use of the IPMS. Results: All participants successfully completed the trial. First, the feasibility of IPMS by observing the number of daily pain assessments recorded among patients was assessed. Second, the users' satisfaction, effectiveness of pain management, and changes in the quality of their lives were evaluated. All the participants gave high satisfaction score after they used IMPS. Both groups reported similar pain scores and KPS scores at the baseline. At the end of the trial, the mean pain score of the trial group was significantly lower than of the control group (P<.001). The ending KPS score of the trial group was significantly higher than of the control group (P<.001). The improvement of pain management knowledge score in the trial group was more pronounced than that in the control group (P<.001). Conclusions: This study provided preliminary data to support the potentials of using IPMS in cancer pain communication between patients and doctors and to provide real-time supportive intervention on a convenient basis at a low cost. Overall, the IPMS can serve as a reliable and effective approach to control cancer pain and improve quality of life for patients with cancer pain. Trial Registration: Clinicaltrials.gov NCT02765269; http://clinicaltrials.gov/ct2/show/NCT02765269 (Archived by WebCite at http://www.webcitation.org/6rnwsgDgv) ", issn="2291-5222", doi="10.2196/mhealth.7178", url="http://mhealth.www.mybigtv.com/2017/7/e108/", url="https://doi.org/10.2196/mhealth.7178", url="http://www.ncbi.nlm.nih.gov/pubmed/28743681" }